195 related articles for article (PubMed ID: 6408181)
1. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
[TBL] [Abstract][Full Text] [Related]
2. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
[TBL] [Abstract][Full Text] [Related]
3. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
Perez HD; Lipton M; Goldstein IM
J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
5. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
Clark RA; Klebanoff SJ
J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
[TBL] [Abstract][Full Text] [Related]
6. Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis.
Perez HD; Horn JK; Ong R; Goldstein IM
J Lab Clin Med; 1983 Jan; 101(1):123-9. PubMed ID: 6848611
[TBL] [Abstract][Full Text] [Related]
7. Chemotactic activity of human blood leukocytes in plasma treated with EDTA: chemoattraction of neutrophils about monocytes is mediated by the generation of NAP-2.
Malawista SE; Van Damme J; Smallwood JI; de Boisfleury Chevance A
J Leukoc Biol; 2002 Jul; 72(1):175-82. PubMed ID: 12101278
[TBL] [Abstract][Full Text] [Related]
8. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
9. Chemotactic factor inactivators of human granulocytes.
Brozna JP; Senior RM; Kreutzer DL; Ward PA
J Clin Invest; 1977 Dec; 60(6):1280-8. PubMed ID: 334799
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
Romualdez AG; Ward PA; Torikata T
J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
[TBL] [Abstract][Full Text] [Related]
11. Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system.
Clark RA; Klebanoff SJ
J Clin Invest; 1979 Oct; 64(4):913-20. PubMed ID: 225353
[TBL] [Abstract][Full Text] [Related]
12. Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes.
O'Flaherty JT; Kreutzer DL; Ward PA
Am J Pathol; 1978 Mar; 90(3):537-50. PubMed ID: 564610
[TBL] [Abstract][Full Text] [Related]
13. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
Donabedian H; Gallin JI
J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
[TBL] [Abstract][Full Text] [Related]
14. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
Azaryan AV; Hook VY
Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma.
Perez HD; Goldstein IM; Webster RO; Henson PM
J Immunol; 1981 Feb; 126(2):800-4. PubMed ID: 7451994
[TBL] [Abstract][Full Text] [Related]
16. Localization and characterization of N-ethylmaleimide sensitive inhibitor(s) of thiol cathepsin activity from cultured nil and polyoma virus-transformed nil hamster cells.
Morgan RA; Inge KL; Christopher CW
J Cell Physiol; 1981 Jul; 108(1):55-66. PubMed ID: 6267078
[TBL] [Abstract][Full Text] [Related]
17. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
Shingu M; Nobunaga M
Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro.
Huber-Lang M; Denk S; Fulda S; Erler E; Kalbitz M; Weckbach S; Schneider EM; Weiss M; Kanse SM; Perl M
Mol Immunol; 2012 Feb; 50(1-2):60-5. PubMed ID: 22244896
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432.
Kato H; Inoue M; Yamamura Y; Tanigawa M; Sano H; Sugino S; Kondo M
Nat Immun Cell Growth Regul; 1989; 8(5):290-300. PubMed ID: 2512482
[TBL] [Abstract][Full Text] [Related]
20. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation.
Muhlfelder TW; Niemetz J; Kreutzer D; Beebe D; Ward PA; Rosenfeld SI
J Clin Invest; 1979 Jan; 63(1):147-50. PubMed ID: 762243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
